期刊文献+

2012年河北与天津静海县接壤地区健康人群脊髓灰质炎中和抗体水平调查 被引量:1

Neutralized Antibody Levels of Poliomyelitis in Healthy Population of Hebei in 2012
原文传递
导出
摘要 目的了解与2012年发现疫苗衍生脊髓灰质炎(脊灰)病毒(VDPV)病例的天津市静海县接壤的河北省4个县健康人群脊髓灰质炎(脊灰)免疫状况,为评估脊灰野病毒输入及疫苗衍生脊灰病毒循环发生提供科学依据。方法调查该4个县〈1岁、1~2岁、3~4岁、5~6岁、7~10岁、11~14岁、15~19岁、≥20岁8个年龄组共465人,采用微量细胞中和实验测定脊灰中和抗体。结果调查人群脊灰中和抗体Ⅰ、Ⅱ、Ⅲ型阳性率分别是97.2%、98.5%和92.7%;抗体滴度中位数分别是1∶128、1∶128和1∶64。结论与天津市静海县接壤的4县健康人群对脊灰病毒形成了良好的免疫屏障。 Objective To investigate poliomyelitis antibody levels among healthy population in Hebei and to provide scientific basis for eliminating the disease.Methods Altogether 465 serum samples were collected in 4 counties of Hebei and microplate neutralization test was employed to determine antibody the levels.Results The positive rates of poliomyelitis antibody were respectively 97.2%,98.5% and 92.7%;antibody titer median for polio type Ⅰ,Ⅱ and Ⅲ were respectively 1:128,1:128 and 1:64.Conclusion The healthy population in the four counties of Hebei has formed qualified immunologic barrier towards poliomyelitis virus.
出处 《预防医学情报杂志》 CAS 2014年第4期307-310,共4页 Journal of Preventive Medicine Information
关键词 脊髓灰质炎 中和抗体 阳性率 抗体滴度 调查 poliomyelitis neutralized antibody positive rate antibody titer
  • 相关文献

参考文献10

二级参考文献20

  • 1Kew O,Morris-Glasgow V,Landaverde M,et al.Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccinederived poliovirus[J].Science,2002,296(5566):356.
  • 2Vinje J,Gregoricus N,Martin J,et al.Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola[J].J Infect Dis,2004,189(7):1168-1175.
  • 3Yang C F,Naguib T,Yang S J,et al.Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993[J].J Virol,2003,77(15):8366-8377.
  • 4Shimizu H,Thorley B,Paladin F J,et al.Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001 [J].J Virol,200478(24):13512-13521.
  • 5Rousset D,Rakoto-Andrianarivelo M,Razafindrdtsimendresy R,et al.Recombinant vaccine derived poliovirus in Madagescar[J].Emerg Infect Dis,2003 9(7):885-887.
  • 6Kew O M,SutterRW.Prolonged replication of a type 1 vaccinederived poliovirus in an immunodeficient patient[J].J Clin Microbiol,1998 36(10):2893-2899.
  • 7Gavrilin G V,Cherkasova E A,Nottay B K,et al.Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient:a unifying model[J].J Virol,2000 74(16):7381-7390.
  • 8WHO.poliolaboratory manual,4th edition [M].Geneva,Switzerland,2004.87 100.
  • 9Balanant J,Guillot S,Candrea A,et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J].Virology,1991,184:645-654.
  • 10CDC.Laboratory surveillance for wild and vaccine-derived polioviruses,January 2002-June 2003 [J].MMWR,2003,52:913-916.

共引文献96

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部